According to a report issued by the British Medical Journal, menstrual symptoms such as heavy bleeding, low mood, and pain may be associated with about 9 days of lost productivity per woman annually. A focus group study depicts that 84.1% women admitted the prevalence of menstrual cramps or primary dysmenorrhea during their menstrual cycles.
Periods are generally linked with mild, tolerable lower abdomen or back discomfort but the pain (dysmenorrhoea) can be acute enough to hinder with quotidian activities. The prevailing remedies in modern healthcare and allopathic medicine system elicit detrimental side effects in long term. In its attempt to deliver a more sustainable, herbal and ayurvedic remedy for menstrual cramps, HempStreet declared the release of medicinal cannabis (Bhaang) based Trailokya Vijaya Vati.
Trailokya Vijaya Vati is an Ayurvedic remedy to this ubiquitous issue. It is a time tested classic medicine, containing cannabis as one of its main ingredients and has been found to be largely efficacious in soft tissue muscle pains such as menstrual cramps and spasms. On the basis of the initial feedback study with 2,000+ Ayurveda clinicians across the nation, the medicine has been observed to be very efficient.
Shrey Jain, co-founder of HempStreet stated-“Menstruation is mostly a stigmatized issue in India. Period pain is often ignored by making an important part of women lifestyle and working hours traumatic and painful. But actually women have felt the cramping pain to be ‘almost as bad as having a heart attack.’ At an average, a woman surpasses about 450 menstrual cycles throughout her life span. Irony is that the prevailing remedies in modern medical science have risk of injurious impacts in case of long haul consumption. Trailokya Vijaya Vati focuses at offering a genuine, safe and ayurvedic solution to the women of 21st century.”
“Hempstreet is toiling simultaneously with world-class scientists to carry out research and development of safe medication by leveraging the vast prospects and natural power of Cannabis. Today HempStreet vaunts of 15 validated products and top-notch research collaboration with Council of Scientific and Industrial Research (CSIR). We have triumphantly reached out to wide network of 43,000 doctors and 230 clinics to supply medical cannabis medicine, mainly to lower the massive menstrual pain relief crisis in the country. The firm seeks to unveil a fruitful and reliable utilization approach of Cannabis, particularly on the pain relief front,” he further said.
The Cannabis Sativa plant, which includes hemp, cannabis, and marijuana, contains over 100 distinct chemicals known as cannabinoids, useful to cure many health conditions such as chronic pain, anxiety, epilepsy, insomnia, menstrual cramps, mental health, muscle spasms, multiple sclerosis, sexual disorders, etc. The legal Cannabis industry is presently one of the tremendously evolving industries across the globe. As per a report by Grand View Research Inc., the global legal marijuana market is estimated to hit USD $146.4 billion by the conclusion of 2025.
Cannabis is considered as one of the five core medicinal plants in Vedas. Cannabis history in India is rooted back to 1000 BC. According to conventional ayurvedic texts, about 191 formulations and over 15 dosage forms contain Cannabis as a major ingredient. Government is working incessantly as Medicinal Marijuana or Cannabis will be legalized very soon. Scientists are energetically working to discern the active components of Cannabis. CSIR Indian Institute of Integrative Medicine is the pioneer institute to receive government consent for Cannabis.
A short while ago, the company has raised $1,000,000 (approximately Rs 8 Crore) in Pre-Series A Funding round. This Pre-Series A funding was run by Pharmacon Holdings, a US-based Pharma Tech company and Romain Berberis, a well-known Private Investor in the field of Cannabis in the US and Canada. The company has strategies to use the funds for brand building, category disruption, research, and tech development, research.
